Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives. | Adv Protein Chem Struct Biol | 2022 | 36088078 | PubTator, text mining | PubMed |
| Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2. | Molecules | 2022 | 36080181 | PubTator, text mining | PubMed |
| Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis. | Int J Mol Sci | 2022 | 36077138 | PubTator, text mining | PubMed |
| Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro. | Nat Commun | 2022 | 36075915 | PubTator, text mining | PubMed |
| The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro). | IUCrJ | 2022 | 36071812 | PubTator, text mining | PubMed |
| Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal. | J Biomed Sci | 2022 | 36064696 | PubTator, text mining | PubMed |
| Rotavirus RNA chaperone mediates global transcriptome-wide increase in RNA backbone flexibility. | Nucleic Acids Res | 2022 | 36062555 | PubTator, text mining | PubMed |
| Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19. | Eur J Med Chem Rep | 2022 | 36060987 | PubTator, text mining | PubMed |
| X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation. | Nat Commun | 2022 | 36057636 | PubTator, text mining | PubMed |
| Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. | Front Pharmacol | 2022 | 36052135 | PubTator, text mining | PubMed |
| Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy. | Front Cell Infect Microbiol | 2022 | 36046742 | PubTator, text mining | PubMed |
| SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength? | Genomics | 2022 | 36041637 | PubTator, text mining | PubMed |
| NMR spectroscopy spotlighting immunogenicity induced by COVID-19 vaccination to mitigate future health concerns. | Curr Res Immunol | 2022 | 36032416 | PubTator, text mining | PubMed |
| The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals. | Front Vet Sci | 2022 | 36032286 | PubTator, text mining | PubMed |
| Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner. | Front Immunol | 2022 | 36032116 | PubTator, text mining | PubMed |
| Stromal Antigen 2 Deficiency Induces Interferon Responses and Restricts Porcine Deltacoronavirus Infection. | Viruses | 2022 | 36016405 | PubTator, text mining | PubMed |
| PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition. | Viruses | 2022 | 36016366 | PubTator, text mining | PubMed |
The Emergence and Pathogenesis of Recombinant Viruses Associated with NADC34-like Strains and the Predominant Circulating Strains of Porcine Reproductive and Respiratory Syndrome Virus in Southern China. | Viruses | 2022 | 36016319 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| A Versatile Class of 1,4,4-Trisubstituted Piperidines Block Coronavirus Replication In Vitro. | Pharmaceuticals (Basel) | 2022 | 36015168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=41